Neuropathological analysis of the brainstem and cerebral cortex lesions on epileptogenesis in hereditary dentatorubral-pallidoluysian atrophy

Brain and Development

Volumn 29, Issue 8, 2007, Pages 473-481

  Hayashi, Masaharu ^a   Kumada, Satoko ^b   Shioda, Kei ^c   Fukatsu, Ryo ^c  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b TOKYO METROPOLITAN NEUROLOGICAL HOSPITAL   (Japan)

^c SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Brainstem; Calcium binding protein; Cerebral cortex; Dentatorubral pallidoluysian atrophy; Immunohistochemistry

Indexed keywords

AMINO ACID TRANSPORTER; CALBINDIN; CALCIUM BINDING PROTEIN; CALRETININ; GLUTAMATE TRANSPORTER; METENKEPHALIN; NEUROPEPTIDE; NEUROTRANSMITTER; PARVALBUMIN; SUBSTANCE P; TRYPTOPHAN HYDROXYLASE; TYROSINE 3 MONOOXYGENASE;

ARTICLE; BRAIN CORTEX LESION; BRAIN REGION; BRAIN STEM INJURY; BRAIN WEIGHT; DENTATORUBROPALLIDOLUYSIAN ATROPHY; EPILEPSY; EPILEPTOGENESIS; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MYOCLONUS EPILEPSY; NEUROPATHOLOGY; PROTEIN EXPRESSION; TEGMENTUM;

ADOLESCENT; ADULT; AGED; BRAIN STEM; CALCIUM-BINDING PROTEINS; CEREBRAL CORTEX; CHILD; EPILEPSY; FEMALE; GLUTAMATE PLASMA MEMBRANE TRANSPORT PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERNEURONS; MALE; MIDDLE AGED; MYOCLONIC EPILEPSIES, PROGRESSIVE; NEUROTRANSMITTER AGENTS;

EID: 34547663174     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.braindev.2006.12.008     Document Type: Article

References (29)

1. Naito H., and Oyanagi S. Familial myoclonus epilepsy and choreoathetosis: hereditary dentatorubral-pallidoluysian atrophy. Neurology 32 (1982) 798-807
2. Koide R., Ikeuchi T., Onodera O., Tanaka H., Igarashi S., Endo K., et al. Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA). Nat Genet 6 (1994) 9-13
3. Tsuchiya K., Oyanagi S., Ikeda K., Arima K., Ando S., Sunohara N., et al. Dentatorubropallidoluysian atrophy: clinicopathological study of eight autopsy cases with special reference to the clinicopathological correlation between pyramidal tract sign and involvement of the pyramidal tract. Neuropathology 15 (1995) 145-153
4. Takeda S., and Takahashi H. Neuropathology of dantatorubropallidoluysian atrophy. Neuropathology 16 (1996) 48-55
5. Yamada M., Wood J.D., Shimohata T., Hayashi S., Tsuji S., Ross C.A., et al. Widespread occurrence of intranuclear atrophin-1 accumulation in the central nervous system neurons of patients with dentatorubral-pallidoluysian atrophy. Ann Neurol 49 (2001) 14-23
6. Hayashi M., Itoh M., Araki S., Kumada S., Tanuma N., Kohji T., et al. Immunohistochemical analysis of brainstem lesions in infantile spasms. Neuropathology 20 (2000) 297-303
7. Hayashi M. Neuropathology of the limbic system and brainstem in West syndrome. Brain Dev 23 (2001) 516-522
8. Proper E.A., Hoogland G., Kappen S.M., Jansen G.H., Rensen M.G., Schrama L.H., et al. Distribution of glutamate transporters in the hippocampus of patients with pharmaco-resistant temporal lobe epilepsy. Brain 125 (2002) 32-43
9. Miyazaki M., Hashimoto T., Nakagawa R., Yoneda Y., Tayama M., Kawano N., et al. Characteristic potentials in childhood-onset dentatorubral-pallidoluysian atrophy. Brain Dev 18 (1996) 389-393
10. Kasai K., Onuma T., Kato M., Kato T., Takeya J., Sekimoto M., et al. Differences in evoked potential characteristics between DRPLA patients and patients with progressive myoclonic epilepsy: preliminary findings indicating usefulness for differential diagnosis. Epilepsy Res 37 (1999) 3-11
11. Touge T., Ichihara N., Ishibashi T., Ikeguchi M., Sasaki I., and Takeuchi H. Afferent and efferent excitabilities of the transcortical loop in patients with dentatorubral-pallidoluysian atrophy. J Neurol Sci 176 (2000) 28-36
12. Pranzatelli M.R., Tate E., Huang Y., Haas R.H., Bodensteiner J., Ashwal S., et al. Neuropharmacology of progressive myoclonus epilepsy: response to 5-hydroxy-l-tryptophan. Epilepsia 36 (1995) 783-791
13. Takeuchi Y., Matsushita H., Sakai H., Kawano H., and Ochi M. Developmental changes in cerebrospinal fluid concentrations of monoamine-related substances in patients with dentatorubral-pallidoluysian atrophy. J Child Neurol 16 (2001) 79-82
14. Hattori H., Higuchi Y., Okuno T., Asato R., Fukumoto M., and Kondo I. Early-childhood progressive myoclonus epilepsy presenting as partial seizures in dentatorubral-pallidoluysian atrophy. Epilepsia 38 (1997) 271-274
15. Arai T., Mizukami K., Matsuzaka H., Iwakuma A., Shiraishi H., and Koizumi J. CNS changes in DRPLA with dementia and personality changes: CT, MR and SPECT findings. Jpn J Psychiatry Neurol 47 (1993) 105-110
16. Uyama E., Kondo I., Uchino M., Fukushima T., Murayama N., Kuwano A., et al. Dentatorubral-pallidoluysian atrophy (DRPLA): clinical, genetic, and neuroradiologic studies in a family. J Neurol Sci 130 (1995) 146-153
17. Andressen C., Blümcke I., and Celio M.R. Calcium-binding proteins: selective markers of nerve cells. Cell Tissue Res 271 (1993) 181-208
18. Seto-Oshima A. Review: calcium-binding proteins in the central nervous system. Acta Histochem Cytochem 27 (1994) 93-106
19. Bu J., Sathyendra V., Nagykery N., and Geula C. Age-related changes in calbindin-D28K, calretinin, and parvalbumin-immunoreactive neurons in the human cortex. Exp Neurol 182 (2003) 220-231
20. Robinson M.B., and Dowd L.A. Heterogeneity and functional properties of subtypes of sodium-dependent glutamate transporters in the mammalian central nervous system. Adv Pharmacol 37 (1997) 69-115
21. Sloviter R.S., Sollas A.L., Barbaro N.M., and Laxer K.D. Calcium-binding protein (calbindin-D28K) and parvalbumin immunohistochemistry in the normal and epileptic human hippocampus. J Comp Neurol 308 (1991) 381-396
22. Ferrer I., Oliver B., Russi A., Casas R., and Rivera R. Parvalbumin and calbindin-D28K immunocytochemistry in human neocortical epileptic foci. J Neurol Sci 123 (1994) 18-25
23. Zhu Z.Q., Armstrong D.L., Hamilton W.J., and Grossman R.G. Disproportionate loss of CA4 parvalbumin-immunoreactive interneurons in patients with Ammon's horn sclerosis. J Neuropathol Exp Neurol 56 (1997) 988-998
24. Mathern G.W., Mendoza D., Lozada A., Pretorius J.K., Dehnes Y., Danbolt N.C., et al. Hippocampal GABA and glutamate transporter immunoreactivity in patients with temporal lobe epilepsy. Neurology 52 (1999) 453-472
25. Mikkonen M., Alafuzoff I., Tapiola T., Soininen H., and Miettinen R. Subfield- and layer-specific changes in parvalbumin, calretinin and calbindin-D28K immunoreactivity in the entorhinal cortex in Alzheimer's disease. Neuroscience 92 (1999) 515-532
26. Beasley C.L., Zhang Z.J., Patten I., and Reynolds G.P. Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins. Biol Psychiatry 52 (2002) 708-715
27. Hachiya Y., Hayashi M., Kumada S., Uchiyama A., Tsuchiya K., and Kurata K. Mechanism of neurodegeneration in neuronal ceroid-lipofuscinosis. Acta Neuropathol 111 (2006) 168-177
28. Hirose M., Yokoyama H., Noguchi R., Haginoya K., Aoki M., and Iinuma K. Improvement of action myoclonus in a patient with dentatorubral-pallidoluysian atrophy by piracetam (in Japanese). No To Hattatsu 36 (2004) 75-79
29. Genton P., Guerrini R., and Remy C. Piracetam in the treatment of cortical myoclonus. Pharmacopsychiatry 32 (1999) 49-53